title: Challenges to conducting a clinical trial of combination therapy of colistin and rifampicin for extensively drug-resistant Acinetobacter baumannii.
authors.affiliation: Division of Infectious Diseases, Department of Medicine, University of Medicine and Dentistry of New Jersey, Newark.
authors.forename: David B
authors.initials: DB
authors.lastname: Huang
authors.forename: Mina
authors.initials: M
authors.lastname: Pastagia
authors.forename: Tom
authors.initials: T
authors.lastname: Chiang
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy*; D040981:Acinetobacter baumannii / Q000187:drug effects*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003091:Colistin / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D008297:Male; D012293:Rifampin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D012293:Rifampin; D003091:Colistin